The Who, What, When, Where, and Why of Bacillus Calmette-Guérin-unresponsive Bladder Cancer.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33454163.
- Also identified by DOI 10.1016/j.eururo.2021.01.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There are several clinical scenarios that may not adhere to the precise definition of bacillus Calmette-Guérin (BCG)-unresponsive bladder cancer, but nevertheless indicate treatment unresponsiveness. We describe four such scenarios as a frame of reference in order to reach a consensus on the enrollment of such patients to current and future clinical trials in the BCG-unresponsive setting.
Medical subject headings
- Urinary Bladder Neoplasms